1 – 10 of 129
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2025
- Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME? (2025)
- Review : livestock cell types with myogenic differentiation potential : considerations for the development of cultured meat (2025) ANIMAL. 19(Suppl. 1).
- 2024
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022) (2024) CANCER IMMUNOLOGY IMMUNOTHERAPY. 74(1).
- Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial (2024) GYNECOLOGIC ONCOLOGY. 191. p.275-286
- Essays on enriching learning experiences in accounting education : dealing with procrastination (2024)
- Effect of porosity on the colonization of digital light-processed 3D hydrogel constructs toward the development of a functional intestinal model (2024) BIOMACROMOLECULES. 25(5). p.2863-2874
- Does practice make perfect? The effect of online formative assessments on students’ self-efficacy and test anxiety (2024) BRITISH ACCOUNTING REVIEW. 56(4).
- Small and medium-sized accounting practices (SMPs) : explaining financial performance based on human capital and organisational resources (2024) ACCOUNTING IN EUROPE. 21(1). p.68-100
- A little push in the back : nudging students to improve procrastination, class attendance and preparation (2024) STUDIES IN HIGHER EDUCATION. 49(11). p.2016-2035
- Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study (2024) NPJ PRECISION ONCOLOGY. 8(1).